| Name | 2-methyl-1-piperazin-1-ylpropan-1-one |
|---|---|
| Synonyms |
1-(2-methylpropanoyl)piperazine
MFCD04973344 1-(2-methylpropionyl)piperazine N-isobutyrylpiperazine 2-methyl-1-(piperazin-1-yl)propan-1-one 1-Isobutanoylpiperazine 1-isobutyrylpiperazine |
| Density | 0.987 g/cm3 |
|---|---|
| Boiling Point | 278.4ºC at 760 mmHg |
| Molecular Formula | C8H16N2O |
| Molecular Weight | 156.22500 |
| Flash Point | 122.2ºC |
| Exact Mass | 156.12600 |
| PSA | 32.34000 |
| LogP | 0.34090 |
| Index of Refraction | 1.465 |
|
~99%
71260-16-7 |
| Literature: BIOMARIN PHARMACEUTICAL INC.; WANG, Bing; CHU, Daniel Patent: WO2011/130661 A1, 2011 ; Location in patent: Page/Page column 98; 106 ; |
|
~%
71260-16-7 |
| Literature: ASTRAZENECA AB; ASTRAZENECA UK LIMITED Patent: WO2004/41829 A1, 2004 ; Location in patent: Page 74 ; WO 2004/041829 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |